0001145549-22-036327.txt : 20220609
0001145549-22-036327.hdr.sgml : 20220609
20220609122034
ACCESSION NUMBER: 0001145549-22-036327
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 3
CONFORMED PERIOD OF REPORT: 20220331
FILED AS OF DATE: 20220609
DATE AS OF CHANGE: 20220609
EFFECTIVENESS DATE: 20220609
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Investment Managers Series Trust II
CENTRAL INDEX KEY: 0001587982
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-22894
FILM NUMBER: 221005364
BUSINESS ADDRESS:
STREET 1: 235 WEST GALENA STREET
CITY: MILWAUKEE
STATE: WI
ZIP: 53212
BUSINESS PHONE: 414-299-2295
MAIL ADDRESS:
STREET 1: 235 WEST GALENA STREET
CITY: MILWAUKEE
STATE: WI
ZIP: 53212
0001587982
S000071987
Sunbridge Capital Emerging Markets Fund
C000227628
Institutional Class
CNRYX
C000227629
Investor Class
RIMIX
0001587982
S000074985
AXS Astoria Inflation Sensitive ETF
C000233574
AXS Astoria Inflation Sensitive ETF
PPI
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0001587982
XXXXXXXX
true
false
false
N-1A
S000074985
true
S000071987
C000227628
C000227629
INVESTMENT MANAGERS SERIES TRUST II
811-22894
0001587982
549300SU7ER9OFETRU41
235 WEST GALENA STREET
MILWAUKEE
532123948
US-WI
US
4142992000
UMB FUND SERVICES, INC.
235 WEST GALENA STREET
MILWAUKEE
53212
4142992000
TRANSFER AGENT, FUND ACCOUNTANT AND CO-ADMINISTRATOR
MUTUAL FUND ADMINISTRATION, LLC
2220 E. ROUTE 66, SUITE 226
GLENDORA
91740
6269144141
CO-ADMINISTRATOR
UMB BANK, N.A.
928 GRAND BOULEVARD, 5TH FLOOR
KANSAS CITY
64106
8168601142
CUSTODIAN
IMST Distributors, LLC
Three Canal Plaza
Suite 100
Portland
04101
8662516920
DISTRIBUTOR
Sunbridge Capital Partners LLC
1200 Brickell Avenue, Suite 620
Miami
33131
8777717721
INVESTMENT ADVISER
AXS Investments LLC
181 Westchester Avenue Suite 402
Port Chester
10573
8332972587
INVESTMENT ADVISER
Astoria Portfolio Advisors LLC
500 7th Avenue, 9th Floor
New York
10018
2123816185
SUB ADVISER
BROWN BROTHERS HARRIMAN & CO.
50 POST OFFICE SQUARE
BOSTON
02110
6177721818
TRANSFER AGENT, FUND ACCOUNTANT AND CUSTODIAN
N
N
N-1A
47
Y
ERIC BANHAZL
N/A
Y
JOHN ZADER
N/A
N
KATHLEEN SHKUDA
N/A
N
LARRY TASHJIAN
N/A
N
TERRANCE P. GALLAGHER
N/A
Y
THOMAS KNIPPER
N/A
N
MARTIN W. DZIURA
N/A
309 WOODRIDGE LANE
MEDIA
19063
XXXXXX
N
N
N
N
N
N
N
IMST DISTRIBUTORS, LLC
8-66389
000130745
N/A
N
N
TAIT, WELLER & BAKER LLP
00445
N/A
N
N
N
N
N
N
N
AXS Astoria Inflation Sensitive ETF
S000074985
5493001KW9J3YXBP6156
Y
1
1
0
Exchange-Traded Fund
Y
N
Y
N
N/A
N/A
N/A
Rule 6c-11 (17 CFR 270.6c-11)
N
N
N
N
AXS Investments LLC
801-117457
000305714
N/A
2021-12-29
Astoria Portfolio Advisors LLC
801-119078
000288271
N/A
N
Brown Brothers Harriman & Co.
85-0000
5493006KMX1VFTPYPW14
N
N
Y
INTERCONTINENTAL EXCHANGE, INC.
5493000F4ZO33MV32P92
N
Refinitiv
549300561UZND4C7B569
N
Y
Brown Brothers Harriman & Co.
5493006KMX1VFTPYPW14
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
RBC INVESTOR SERVICES TRUST FOR RBC
5493002MUOV04NSPT571
CA
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
Y
BROWN BROTHERS HARRIMAN & CO.
5493006KMX1VFTPYPW14
LEI
N
N
Y
MUTUAL FUND ADMINISTRATION, LLC
N/A
Y
N
UMB FUND SERVICES, INC.
084-05792
SEC File Number
Y
N
Y
ABN AMRO CLEARING BANK N.V.
N/A
N/A
N/A
NL
428.000000000000
VIRTU ITG LLC
008-44218
000029299
549300S41SMIODVIT266
1061.000000000000
1489.000000000000
ABN AMRO CLEARING BANK N.V.
N/A
N/A
N/A
NL
854955.000000000000
VIRTU ITG LLC
008-44218
000029299
549300S41SMIODVIT266
7212235.000000000000
8067190.000000000000
N
26805598.000000000000
0.000000000000
N
N
N
N
Sunbridge Capital Emerging Markets Fund
S000071987
549300KQCNM9MLD6M411
N
2
0
0
N/A
Y
N
Y
N
N/A
N/A
N/A
Rule 32a-4 (17 CFR 270.32a-4)
Y
Y
N
N
Sunbridge Capital Partners LLC
801-120375
000312611
N/A
N
UMB FUND SERVICES, INC.
84-5792
N/A
Y
N
Y
INTERCONTINENTAL EXCHANGE, INC.
5493000F4ZO33MV32P92
N
N
UMB BANK, NATIONAL ASSOCIATION
VNOO6EITDJ2YUEBMSZ83
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
CITIBANK, N.A., SAO PAULO
N/A
BR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
EUROCLEAR BK SA NV
N/A
XX
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
BNPPSS FRANKFURT
N/A
DE
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
SCB (HONG KONG) LTD
N/A
HK
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
HSBC HONG KONG
N/A
HK
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
CITIBANK MUMBAI
N/A
IN
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
CITIBANK JAKARTA
N/A
ID
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
CITIBANK KOREA INC
N/A
KR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
SCB MALAYSIA BERHAD
N/A
MY
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
BNPPSS NETHERLANDS
N/A
NL
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
SCB PHILIPPINES
N/A
PH
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
DBS BANK LTD
N/A
SG
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
HSBC SRI LANKA
N/A
LK
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
SCB (TAIWAN) LTD
N/A
TW
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
HSBC THAILAND
N/A
TH
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
HSBC BK (VIETNAM)
N/A
VN
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
N
UMB FUND SERVICES, INC.
084-05792
SEC File Number
Y
N
Y
UMB FUND SERVICES, INC.
084-05792
SEC File Number
Y
N
MUTUAL FUND ADMINISTRATION, LLC
N/A
N/A
Y
N
Y
BANC OF AMERICA SECURITIES LLC
8-42263
000026091
N/A
310819.000000000000
DAIWA CAPITAL MARKETS AMERICA INC.
8-12242
000001576
M67H5PRC0NQKM73ZAS82
261278.000000000000
UBS SECURITIES LLC
8-22651
000007654
T6FIZBDPKLYJKFCRVK44
186649.000000000000
CREDIT SUISSE SECURITIES (USA) LLC
8-422
000000816
1V8Y6QCX6YMJ2OELII46
105101.000000000000
MACQUARIE CAPITAL (USA) INC.
8-47198
000036368
549300670K07JRB5UQ40
99285.000000000000
ICICI SECURITIES INC.
8-52746
000104285
N/A
83868.000000000000
CITIGROUP GLOBAL MARKETS INC.
8-8177
000007059
6SHGI4ZSSLCXXQSBB395
77608.000000000000
HSBC SECURITIES (USA) INC.
8-41562
000019585
CYYGQCGNHMHPSMRL3R97
70612.000000000000
JEFFERIES LLC
8-15074
000002347
58PU97L1C0WSRCWADL48
67472.000000000000
GOLDMAN SACHS & CO. LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
33161.000000000000
1372302.000000000000
KOTAK SECURITIES LIMITED
N/A
N/A
335800UUZDPJ7XGOFU74
IN
6936162.000000000000
CREDIT SUISSE SECURITIES (USA) LLC
8-422
000000816
1V8Y6QCX6YMJ2OELII46
711659.000000000000
MORGAN STANLEY
8-68191
000149777
9R7GPTSO7KV3UQJZQ078
31800.000000000000
7679621.000000000000
Y
549410911.000000000000
0.000000000000
N
N
N
N
AXS Astoria Inflation Sensitive ETF
S000074985
N
25000.000000000000
0.510000000000
0.150000000000
99.490000000000
0.150000000000
0.000000000000
0.000000000000
0.000000000000
0.000000000000
350.000000000000
0.000000000000
0.000000000000
350.000000000000
0.000000000000
0.000000000000
350.000000000000
0.000000000000
0.000000000000
350.000000000000
0.000000000000
0.000000000000
Y
true
INTERNAL CONTROL RPT
2
axsastoriancen.txt
INTERNAL CONTROL
REPORT OF INDEPENDENT
REGISTERED PUBLIC
ACCOUNTING FIRM
To the Shareholders and
Board of Trustees of
Investment Managers Series Trust II
Milwaukee, Wisconsin 53212
In planning and performing our audit of
the financial statements of AXS Astoria
Inflation Sensitive ETF (the Fund), a
series of Investment Managers Series
Trust II, as of and for the period ended
March 31, 2022, in accordance with the
standards of the Public Company
Accounting Oversight Board (United
States), we considered their internal
control over financial reporting,
including control activities for
safeguarding securities, as a basis for
designing our auditing procedures for the
purpose of expressing our opinion on the
financial statements and to comply with
the requirements of Form N-CEN, but
not for the purpose of expressing an
opinion on the effectiveness of the Funds
internal control over financial reporting.
Accordingly, we express no such
opinion.
The management of the Fund is
responsible for establishing and
maintaining effective internal control
over financial reporting. In fulfilling this
responsibility, estimates and judgments
by management are required to assess the
expected benefits and related costs of
controls. A companys internal control
over financial reporting is a process
designed to provide reasonable assurance
regarding the reliability of financial
reporting and the preparation of financial
statements for external purposes in
accordance with generally accepted
accounting principles. A companys
internal control over financial reporting
includes those policies and procedures
that (1) pertain to the maintenance of
records that, in reasonable detail,
accurately and fairly reflect the
transactions and dispositions of the assets
of the company; (2) provide reasonable
assurance that transactions are recorded
as necessary to permit preparation of
financial statements in accordance with
generally accepted accounting principles,
and that receipts and expenditures of the
company are being made only in
accordance with authorizations of
management and directors of the
company; and (3) provide reasonable
assurance regarding prevention or timely
detection of unauthorized acquisition, use
or disposition of a companys assets that
could have a material effect on the
financial statements.
Because of inherent limitations, internal
control over financial reporting may not
prevent or detect misstatements. Also,
projections of any evaluation of
effectiveness to future periods are subject
to the risk that controls may become
inadequate because of changes in
conditions, or that the degree of
compliance with the policies or
procedures may deteriorate.
A deficiency in internal control over
financial reporting exists when the design
or operation of a control does not allow
management or employees, in the normal
course of performing their assigned
functions, to prevent or detect
misstatements on a timely basis. A
material weakness is a deficiency, or
combination of deficiencies, in internal
control over financial reporting, such that
there is a reasonable possibility that a
material misstatement of the companys
annual or interim financial statements
will not be prevented or detected on a
timely basis.
Our consideration of the Funds internal
control over financial reporting was for
the limited purpose described in the first
paragraph and would not necessarily
disclose all deficiencies in internal
control that might be material
weaknesses under standards established
by the Public Company Accounting
Oversight Board (United States).
However, we noted no deficiencies in the
Funds internal control over financial
reporting and its operation, including
controls for safeguarding securities,
which we consider to be material
weaknesses, as defined above, as of
March 31, 2022.
This report is intended solely for the
information and use of management,
Shareholders and Board of Trustees of
Investment Managers Series Trust II and
the Securities and Exchange
Commission, and is not intended to be
and should not be used by anyone other
than these specified parties.
/s/TAIT, WELLER & BAKER LLP
Philadelphia, Pennsylvania
May 27, 2022
To the Shareholders and
Board of Trustees of
Investment Managers Series Trust II
Page Two
INTERNAL CONTROL RPT
3
sunbridgecapitalncen.txt
INTERNAL CONTROL
REPORT OF INDEPENDENT
REGISTERED PUBLIC
ACCOUNTING FIRM
To the Shareholders and
Board of Trustees of
Investment Managers Series Trust II
Milwaukee, Wisconsin 53212
In planning and performing our audit of
the financial statements of Sunbridge
Capital Emerging Markets Fund (the
Fund), a series of Investment Managers
Series Trust II, as of and for the period
ended March 31, 2022, in accordance
with the standards of the Public
Company Accounting Oversight Board
(United States), we considered their
internal control over financial reporting,
including control activities for
safeguarding securities, as a basis for
designing our auditing procedures for the
purpose of expressing our opinion on the
financial statements and to comply with
the requirements of Form N-CEN, but
not for the purpose of expressing an
opinion on the effectiveness of the Funds
internal control over financial reporting.
Accordingly, we express no such
opinion.
The management of the Fund is
responsible for establishing and
maintaining effective internal control
over financial reporting. In fulfilling this
responsibility, estimates and judgments
by management are required to assess the
expected benefits and related costs of
controls. A companys internal control
over financial reporting is a process
designed to provide reasonable assurance
regarding the reliability of financial
reporting and the preparation of financial
statements for external purposes in
accordance with generally accepted
accounting principles. A companys
internal control over financial reporting
includes those policies and procedures
that (1) pertain to the maintenance of
records that, in reasonable detail,
accurately and fairly reflect the
transactions and dispositions of the assets
of the company; (2) provide reasonable
assurance that transactions are recorded
as necessary to permit preparation of
financial statements in accordance with
generally accepted accounting principles,
and that receipts and expenditures of the
company are being made only in
accordance with authorizations of
management and directors of the
company; and (3) provide reasonable
assurance regarding prevention or timely
detection of unauthorized acquisition, use
or disposition of a companys assets that
could have a material effect on the
financial statements.
Because of inherent limitations, internal
control over financial reporting may not
prevent or detect misstatements. Also,
projections of any evaluation of
effectiveness to future periods are subject
to the risk that controls may become
inadequate because of changes in
conditions, or that the degree of
compliance with the policies or
procedures may deteriorate.
A deficiency in internal control over
financial reporting exists when the design
or operation of a control does not allow
management or employees, in the normal
course of performing their assigned
functions, to prevent or detect
misstatements on a timely basis. A
material weakness is a deficiency, or
combination of deficiencies, in internal
control over financial reporting, such that
there is a reasonable possibility that a
material misstatement of the companys
annual or interim financial statements
will not be prevented or detected on a
timely basis.
Our consideration of the Funds internal
control over financial reporting was for
the limited purpose described in the first
paragraph and would not necessarily
disclose all deficiencies in internal control
that might be material weaknesses under
standards established by the Public
Company Accounting Oversight Board
(United States). However, we noted no
deficiencies in the Funds internal control
over financial reporting and its operation,
including controls for safeguarding
securities, which we consider to be
material weaknesses, as defined above, as
of March 31, 2022.
This report is intended solely for the
information and use of management,
Shareholders and Board of Trustees of
Investment Managers Series Trust II and
the Securities and Exchange Commission,
and is not intended to be and should not be
used by anyone other than these specified
parties.
/s/TAIT, WELLER & BAKER LLP
Philadelphia, Pennsylvania
May 27, 2022
To the Shareholders and
Board of Trustees of
Investment Managers Series Trust II
Page Two